Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Industry News

Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years

July 08, 2019

News Industry News

Abott Implements Corrective Action for Heartmate 3 Heart Pump

May 07, 2018

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Industry News

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

November 15, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

Clinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014

September 16, 2014

News Industry News

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

September 09, 2014

News Industry News

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

June 27, 2014

News Industry News

Sunshine Heart to Feature Initial European OPTIONS HF Data at 2013 Transcatheter Cardiovascular Therapeutics Conference

October 22, 2013

News Industry News

JARVIK HEART Announces Full FDA Approval of the Jarvik 2000 Destination Therapy Trial

August 14, 2012

News Industry News

Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference

November 06, 2011

Advertisement

Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years

Abott Implements Corrective Action for Heartmate 3 Heart Pump

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Clinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

Sunshine Heart to Feature Initial European OPTIONS HF Data at 2013 Transcatheter Cardiovascular Therapeutics Conference

JARVIK HEART Announces Full FDA Approval of the Jarvik 2000 Destination Therapy Trial

Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content